![Patient Diversity: Strategies and Organizational Approaches](https://isrreports.com/wp-content/uploads/2024/05/preview-image-2024-Patient-Diversity-Strategies-Organizational-Approaches-1024x632.png)
Report Overview: Appropriate demographic representation in clinical trials can help ensure that a therapy’s effects, including safety and efficacy outcomes, are understood across various patient characteristics such as race/ethnicity, gender, age, health status, socioeconomic status, and geographic location. Individuals from…
![](https://isrreports.com/wp-content/uploads/2023/09/preview-image-2023-eCOA-ePRO-Benchmarking-and-Marketing-Dynamics_5e_700.png)
Empowering Clinical Excellence: eCOA/ePRO Provider Insights Although patient reported outcomes (PROs) and clinical outcomes assessments (COAs) were originally collected and reviewed on paper, their electronic successors (eCOA/ePRO) have thoroughly eclipsed paper as the preferred data collection method. The whole clinical…
![Five Steps to CRO Selection](https://isrreports.com/wp-content/uploads/2023/08/feature-image-five-steps-to-cro-selection_1200-1024x632.png)
Sponsors can facilitate successful CRO partnerships by clearly defining the goals of the clinical trial, choosing an outsourcing model that considers project needs and internal capabilities/resources appropriately, communicating consistently and effectively during the decision-making process, and informing provider selection with…
Perspectives on Clinical Development Outsourcing Outsourcing plays a vital role in the clinical development programs of biopharmaceutical companies, offering increased flexibility; access to external expertise and technological advancements; and improved efficiency. Our research on clinical development outsourcing models provides valuable…
![](https://isrreports.com/wp-content/uploads/2023/07/preview-image-2023-Clinical-Development-Outsourcing-Models_5e.png)
Clinical Development Outsourcing Models (5th Ed.) Outsourcing has become a crucial component of clinical development programs for many biopharmaceutical companies. The practice allows for increased flexibility in resourcing and enables sponsors to leverage external expertise, access innovative technologies, and gain…